LadRx (CYTR) News Today → The asset beating inflation by 4x (From Colonial Metals) (Ad) Free CYTR Stock Alerts Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineLadRx Corporation (LADX) Stock Historical Prices & Data - Yahoo Financefinance.yahoo.com - August 11 at 11:13 AMLadRx Corporation Issues Corporate Update for 3Q22finance.yahoo.com - November 27 at 9:41 AMLadRx Corporation Announces OTCQB Ticker Change to LADX - Business Wirebusinesswire.com - October 5 at 11:30 PMCYTRX CORP : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) - Marketscreener.commarketscreener.com - September 23 at 1:49 PMCytRx Corporation Relaunches as LadRx Corporation - Business Wirebusinesswire.com - September 23 at 12:04 PMEuropean Patent Office Awards CytRx Key Patent - Business Wirebusinesswire.com - September 7 at 12:27 PMADIAL PHARMACEUTICALS, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K) - Marketscreener.commarketscreener.com - August 25 at 5:21 PMCYTR.PK - CytRx Corporation | Stock Price & Latest News | Reutersreuters.com - August 21 at 8:36 PMCytRx Welcomes Cary J. Claiborne to the CytRx Board of Directors - Business Wirebusinesswire.com - August 9 at 4:22 PMCytRx Welcomes Cary J. Claiborne to the CytRx Board of Directorsfinance.yahoo.com - August 9 at 8:50 AMCYTRX CORP : Submission of Matters to a Vote of Security Holders (form 8-K) - Marketscreener.commarketscreener.com - July 27 at 6:39 PM2022-05-19 | OTCQB:CYTR | Press Release | CytRx Corporation - Stockhousestockhouse.com - May 20 at 5:13 AMCytRx Announces Distribution of Series D Preferred Stock to Holders of Its Common Stock - Business Wirebusinesswire.com - May 20 at 5:13 AMCYTRX CORP : Material Modification to Rights of Security Holders, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) - Marketscreener.commarketscreener.com - May 20 at 3:07 AMCytRx Announces Distribution of Series D Preferred Stock to Holders of Its Common Stock - Yahoo Financefinance.yahoo.com - May 19 at 11:17 PMCytRx Announces Distribution of Series D Preferred Stock to Holders of Its Common Stock - Marketscreener.commarketscreener.com - May 19 at 9:14 PMCytRx Highlights Strategic Purchase of Arimoclomol by KemPharm, Inc.finance.yahoo.com - May 17 at 8:33 AMArcellx (ACLX) Appoints Olivia Ware to its Board - StreetInsider.comstreetinsider.com - May 16 at 5:26 PMCytRx Partners with Oncology Development Expert to Advance LADR Platform - Business Wirebusinesswire.com - April 20 at 10:59 AMCytRx Partners with Oncology Development Expert to Advance LADR Platformfinance.yahoo.com - April 20 at 10:59 AMGene Therapies & Associated Vectors 2022: Intellectual Property Landscape, Patent Valuation Analysis, Granted Patents and Claims Analysis - PR Newswireprnewswire.com - April 13 at 1:23 PMForm 424B3 CYTRX CORP - StreetInsider.comstreetinsider.com - March 25 at 11:03 PMCytRx Issues Open Letter to Stockholders Regarding Recent Corporate Progress - Benzinga - Benzingabenzinga.com - March 23 at 3:33 PMCYTRX CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K) - Marketscreener.commarketscreener.com - March 23 at 8:55 AMCytRx Issues Open Letter to Stockholders Regarding Recent Corporate Progress - Yahoo Financefinance.yahoo.com - March 21 at 10:05 AMCytRx Issues Open Letter to Stockholders Regarding Recent Corporate Progressfinance.yahoo.com - March 21 at 10:05 AMOrphazyme Calls For Court-Mediated Restructuring, Lays Off 50% Workforce By Benzinga - Investing.com UKuk.investing.com - March 12 at 5:30 AMOrphazyme Calls For Court-Mediated Restructuring, Lays Off 50% Workforce - Benzinga - Benzingabenzinga.com - March 11 at 2:27 PMCytRx Announces Integration of Wholly Owned Subsidiary Centurion BioPharma and Corporate Governance Updates - Business Wirebusinesswire.com - March 10 at 11:26 PMCytRx to absorb subsidiary Centurion BioPharma; former CEO retires from boardseekingalpha.com - March 9 at 9:11 PMCytRx Announces Integration of Wholly Owned Subsidiary Centurion BioPharma and Corporate Governance Updates - Yahoo Financefinance.yahoo.com - March 9 at 10:54 AMInvestor Presentation: February 2022 - marketscreener.commarketscreener.com - February 26 at 1:17 AMHealth Care Sector Update for 02/24/2022: ORPH,CYTR,FEMY,CLRB,EVH,LNTH - Nasdaqnasdaq.com - February 24 at 5:58 PMCytRx Comments on Orphazyme's Update on European Union Regulatory Review of Arimoclomol in Niemann-Pick Disease Type Cfinance.yahoo.com - February 24 at 8:59 AMCytRx : FAQ on Issuance of Shares to Armistice Capital and Special Meeting of Shareholders to Approve Increase in Authorized Shares - Form 8-K - marketscreener.commarketscreener.com - February 17 at 5:33 PMCytRx Highlights Orphazyme's Update on Planned NDA Resubmission for Arimoclomol in Niemann-Pick Disease Type C - Business Wirebusinesswire.com - February 14 at 3:21 PMCytRx Highlights Orphazyme's Update on Planned NDA Resubmission for Arimoclomol in Niemann-Pick Disease Type Cfinance.yahoo.com - February 14 at 10:20 AMOrphazyme gains on plans to resubmit U.S. marketing application for arimoclomol - Seeking Alphaseekingalpha.com - February 11 at 11:48 AMCYTRX CORP : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) - marketscreener.commarketscreener.com - January 26 at 7:47 AMCytRx : Shareholder Letter, mailed on January 25, 2022 (furnished herewith pursuant to Item 7.01) - Form 8-K - marketscreener.commarketscreener.com - January 26 at 7:47 AMCytRx to Hold Town Hall for Stockholders on Thursday, January 20thfinance.yahoo.com - January 18 at 9:30 AMCytRx to Participate in the H.C. Wainwright BioConnect Virtual Conference - marketscreener.commarketscreener.com - January 7 at 10:50 AMOculis appoints Mr. Webb Ding as Global Chief Operating Officer and General Manager (China) - Yahoo Finance UKuk.finance.yahoo.com - January 5 at 7:20 AMCytRx : Announces the Appointment of Dr. Stephen Snowdy as Chief Executive Officer - Form 8-K - marketscreener.commarketscreener.com - January 4 at 7:51 PMCYTRX CORP : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) - marketscreener.commarketscreener.com - January 4 at 9:50 AMCytRx Announces the Appointment of Dr. Stephen Snowdy as Chief Executive Officer - Business Wirebusinesswire.com - January 3 at 8:10 AMCytRx Announces the Appointment of Dr. Stephen Snowdy as Chief Executive Officerfinance.yahoo.com - January 3 at 8:10 AMImmunityBio pares gains following aldoxorubicin data in cancer - Seeking Alphaseekingalpha.com - December 28 at 1:32 PMCytRx Highlights ImmunityBio's Use of Aldoxorubicin in Ongoing Clinical Studies for Various Forms of Cancer - Business Wirebusinesswire.com - December 22 at 1:13 PMCytRx Highlights ImmunityBio's Use of Aldoxorubicin in Ongoing Clinical Studies for Various Forms of Cancer - Yahoo Financefinance.yahoo.com - December 21 at 8:29 AM Get LadRx News Delivered to You Automatically Sign up to receive the latest news and ratings for CYTR and its competitors with MarketBeat's FREE daily newsletter. Email Address Global crypto currency reset (41 major banks signed up) (Ad)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know. CYTR Media Mentions By Week CYTR Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CYTR News Sentiment▼0.000.42▲Average Medical News Sentiment CYTR News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CYTR Articles This Week▼00▲CYTR Articles Average Week Get LadRx News Delivered to You Automatically Sign up to receive the latest news and ratings for CYTR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: TCON News FNCH News KRBP News PALI News ALBT News ELOX News FRTX News GMDA News CELZ News TTNP News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:CYTR) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchCould Your Accounts Be Frozen?Allegiance GoldThe Gold Grab of the CenturyColonial MetalsStock-Picking AI Predicts #1 Stock of 2024AltimetryThe only AI company you should be looking atBehind the MarketsThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LadRx Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
